4//SEC Filing
GIVEN DOUGLAS B 4
Accession 0001209191-21-004076
CIK 0000879407other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:58 PM ET
Size
7.5 KB
Accession
0001209191-21-004076
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2021-01-15$83.28/sh−3,000$249,840→ 12,500 total(indirect: By Trust)
Holdings
- 119,368
Common Stock
- 15,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.98 to $83.40, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.
- [F3]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- [F4]Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001156207
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:58 PM ET
- Size
- 7.5 KB